Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Statistics

Total Valuation

ZVRA has a market cap or net worth of $435.01 million. The enterprise value is $405.56 million.

Market Cap	435.01M
Enterprise Value	405.56M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ZVRA has 53.38 million shares outstanding. The number of shares has increased by 23.73% in one year.

Current Share Class	53.38M
Shares Outstanding	53.38M
Shares Change (YoY)	+23.73%
Shares Change (QoQ)	+14.10%
Owned by Insiders (%)	6.18%
Owned by Institutions (%)	41.71%
Float	43.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.16
Forward PS	5.55
PB Ratio	6.22
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	16.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.86.

Current Ratio	2.88
Quick Ratio	2.82
Debt / Equity	0.86
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.67

Financial Efficiency

Return on equity (ROE) is -130.67% and return on invested capital (ROIC) is -44.81%.

Return on Equity (ROE)	-130.67%
Return on Assets (ROA)	-32.80%
Return on Capital (ROIC)	-44.81%
Revenue Per Employee	$354,913
Profits Per Employee	-$1.30M
Employee Count	69
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.48% in the last 52 weeks. The beta is 2.01, so ZVRA's price volatility has been higher than the market average.

Beta (5Y)	2.01
52-Week Price Change	+42.48%
50-Day Moving Average	8.70
200-Day Moving Average	6.81
Relative Strength Index (RSI)	45.71
Average Volume (20 Days)	499,420

Short Selling Information

The latest short interest is 4.67 million, so 8.75% of the outstanding shares have been sold short.

Short Interest	4.67M
Short Previous Month	4.07M
Short % of Shares Out	8.75%
Short % of Float	10.83%
Short Ratio (days to cover)	9.18

Income Statement

In the last 12 months, ZVRA had revenue of $24.49 million and -$89.66 million in losses. Loss per share was -$2.11.

Revenue	24.49M
Gross Profit	16.44M
Operating Income	-86.74M
Pretax Income	-50.87M
Net Income	-89.66M
EBITDA	-81.22M
EBIT	-86.74M
Loss Per Share	-$2.11

Balance Sheet

The company has $89.38 million in cash and $59.93 million in debt, giving a net cash position of $29.45 million or $0.55 per share.

Cash & Cash Equivalents	89.38M
Total Debt	59.93M
Net Cash	29.45M
Net Cash Per Share	$0.55
Equity (Book Value)	69.77M
Book Value Per Share	1.31
Working Capital	64.96M

Cash Flow

In the last 12 months, operating cash flow was -$69.57 million and capital expenditures -$72,000, giving a free cash flow of -$69.65 million.

Operating Cash Flow	-69.57M
Capital Expenditures	-72,000
Free Cash Flow	-69.65M
FCF Per Share	-$1.30

Margins

Gross Margin	67.13%
Operating Margin	-354.22%
Pretax Margin	-366.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ZVRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.73%
Shareholder Yield	-23.73%
Earnings Yield	-20.61%
FCF Yield	-16.01%

Analyst Forecast

The average price target for ZVRA is $21.20, which is 160.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.20
Price Target Difference	160.12%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	54.76%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 28, 2020. It was a reverse split with a ratio of 0.0625:1.

Last Split Date	Dec 28, 2020
Split Type	Reverse
Split Ratio	0.0625:1

Scores

ZVRA has an Altman Z-Score of -3.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.21
Piotroski F-Score	2